Psychopharmacology

EP254:Triangulating genetic evidence & dodging bias to pick winning drug targets with Brent Richards

More or different? Thoughts on the mechanisms of psychedelics - Prof. Dr. David Nutt

Psychedelika und psychische Gesundheit: Wo stehen wir und wo wollen wir hin? – Prof. Dr. Gründer

Jornada- La problemática del fentanilo

Journey- The fentanyl problem

Jornada- Uso y abuso de los antidepresivos

Journey- Use and abuse of antidepressants

Dr. Michel Sabé - Psychedelics & Schizophrenia: Rethinking Care for Negative and Depressive symptoms

Exploring the psychology of psychedelic experiences | SLICE SCIENCE | FULL DOC

Dr. Natasha Mason — LSD, Brain Synchrony & Prosocial Behavior

Dr. Lisa Luan — Acute Subjective and EEG Effects of Extended DMT Administration

Dr. Friederike Holze — Clinical Pharmacology of Classical Psychedelics

Keynote Speaker - Professor David Nutt

Virtual Reality and Psychoplastogens: Toward pharmacologically altered VR Treatments | Hector Taylor

Forum Bewusstseinskultur: From Illusions to Solutions - How Could Psychedelics Make a Contribution?

Psychedelic Prescribing in Australia: Local Challenges and Opportunities, Global Lessons

Increased Plasticity in Hippocampus and Prefrontal Cortex Following Psychedelic Administration

From Concept to Funding & Development: A Negev Labs Psychedelic Drug Discovery Platform

Allosteric BDNF-TrkB Signalling as the Target for Psychedelic and Antidepressant Drugs

What Do You Want To Know: An Opportunity To Discuss Naive and Not So Naive Questions

How Psilocin and a Serotonin Blocker Affect Brain Responses to Sound in Rats

The Curious Case of LSD: a pre-clinical perspective

The Psychedelic Experience: Dive into the inner workings of psychedelic journeys (full documentary)

Psychedelics in Psychiatry - an Incremental Step Forward or a Paradigm Shift?

Psychedelic Research at NUDZ and in the Czech Republic

Psychedelic Therapeutics: Behind the Scenes

Symposium: The Value of Real World Evidence in Psychedelic Research

Psychedelics and The ‘Inner Healer’: Myth or Mechanism?

Symposium: Bridging the Gap Between Basic Science and Research in Psychedelic Neuroscience (Part 3)

Symposium: Bridging the Gap Between Basic Science and Research in Psychedelic Neuroscience (Part 1)

Symposium Bridging the Gap Between Basic Science and Research in Psychedelic Neuroscience (Part 4)

Psilocybin and DMT for Depression

Lysergic Acid Diethylamide Induces Changes in Fractional Anisotropy in Patients with Depression

Acute Effects of Different Psychedelics and Their Interaction with Other Medications

The Drug To Master Reality

II Encuentro de la Red de Investigadores sobre Fármacos y Diagnósticos. DÍA 2

II Meeting of the Research Network on Drugs and Diagnostics. DAY 2

II Encuentro Fármacos y Diagnósticos. DÍA 1

II Meeting on Drugs and Diagnostics. DAY 1